Eli Lilly (LLY) Revenue (2009 - 2026)
Eli Lilly posted quarterly Revenue of $19.8 billion for Q1 2026, up 55.54% year-on-year from $12.7 billion in Q1 2025, and up 2.63% on a QoQ basis from $19.3 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Revenue data on file, last reported at $19.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 55.54% year-over-year to $19.8 billion; the trailing twelve-month figure through Mar 2026 stood at $72.2 billion (up 47.44% YoY), and the FY2025 full-year result was $65.2 billion, up 44.7% from the prior year.
- Revenue for Q1 2026 stood at $19.8 billion, up from $19.3 billion in the prior quarter.
- Across five years, Revenue topped out at $19.8 billion in Q1 2026 and bottomed at $6.5 billion in Q2 2022.
- The 5-year median for Revenue is $9.5 billion (2023), against an average of $11.3 billion.
- The widest annual swing landed in 2023, when Revenue declined 10.88%; it then jumped 55.54% in 2026.
- A 5-year view of Revenue shows it stood at $7.3 billion in 2022, then advanced by 28.1% to $9.4 billion in 2023, then jumped by 44.69% to $13.5 billion in 2024, then surged by 42.55% to $19.3 billion in 2025, then rose by 2.63% to $19.8 billion in 2026.
- The last three Revenue figures came in at $19.8 billion (Q1 2026), $19.3 billion (Q4 2025), and $17.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 19.80 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 24.06 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 15.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 11.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.80 Bn |
| Dec 31, 2025 | 19.29 Bn |
| Sep 30, 2025 | 17.60 Bn |
| Jun 30, 2025 | 15.56 Bn |
| Mar 31, 2025 | 12.73 Bn |
| Dec 31, 2024 | 13.53 Bn |
| Sep 30, 2024 | 11.44 Bn |
| Jun 30, 2024 | 11.30 Bn |
| Mar 31, 2024 | 8.77 Bn |
| Dec 31, 2023 | 9.35 Bn |
| Sep 30, 2023 | 9.50 Bn |
| Jun 30, 2023 | 8.31 Bn |
| Mar 31, 2023 | 6.96 Bn |
| Dec 31, 2022 | 7.30 Bn |
| Sep 30, 2022 | 6.94 Bn |
| Jun 30, 2022 | 6.49 Bn |
| Mar 31, 2022 | 7.81 Bn |
| Dec 31, 2021 | 8.00 Bn |
| Sep 30, 2021 | 6.77 Bn |
| Jun 30, 2021 | 6.74 Bn |
| Mar 31, 2021 | 6.81 Bn |
| Dec 31, 2020 | 7.44 Bn |
| Sep 30, 2020 | 5.74 Bn |
| Jun 30, 2020 | 5.50 Bn |
| Mar 31, 2020 | 5.86 Bn |
| Dec 31, 2019 | 6.11 Bn |
| Sep 30, 2019 | 5.48 Bn |
| Jun 30, 2019 | 5.64 Bn |
| Mar 31, 2019 | 5.09 Bn |
| Dec 31, 2018 | 5.64 Bn |
| Sep 30, 2018 | 5.31 Bn |
| Jun 30, 2018 | 5.59 Bn |
| Mar 31, 2018 | 4.96 Bn |
| Dec 31, 2017 | 6.16 Bn |
| Sep 30, 2017 | 5.66 Bn |
| Jun 30, 2017 | 5.82 Bn |
| Mar 31, 2017 | 5.23 Bn |
| Dec 31, 2016 | 5.76 Bn |
| Sep 30, 2016 | 5.19 Bn |
| Jun 30, 2016 | 5.40 Bn |
| Mar 31, 2016 | 4.87 Bn |
| Dec 31, 2015 | 5.38 Bn |
| Sep 30, 2015 | 4.96 Bn |
| Jun 30, 2015 | 4.98 Bn |
| Mar 31, 2015 | 4.64 Bn |
| Dec 31, 2014 | 5.12 Bn |
| Sep 30, 2014 | 4.88 Bn |
| Jun 30, 2014 | 4.94 Bn |
| Mar 31, 2014 | 4.68 Bn |
| Dec 31, 2013 | 5.81 Bn |
| Sep 30, 2013 | 5.77 Bn |
| Jun 30, 2013 | 5.93 Bn |
| Mar 31, 2013 | 5.60 Bn |
| Dec 31, 2012 | 5.96 Bn |
| Sep 30, 2012 | 5.44 Bn |
| Jun 30, 2012 | 5.60 Bn |
| Mar 31, 2012 | 5.60 Bn |
| Dec 31, 2011 | 6.05 Bn |
| Sep 30, 2011 | 6.15 Bn |
| Jun 30, 2011 | 6.25 Bn |
| Mar 31, 2011 | 5.84 Bn |
| Dec 31, 2010 | 6.19 Bn |
| Sep 30, 2010 | 5.49 Bn |
| Jun 30, 2010 | 5.59 Bn |
| Mar 31, 2010 | 5.49 Bn |
| Dec 31, 2009 | 5.93 Bn |
| Sep 30, 2009 | 5.39 Bn |
| Jun 30, 2009 | 5.29 Bn |
| Mar 31, 2009 | 5.05 Bn |